文献速递神经肿瘤

磁共振成像中的无强化边缘和软脑膜侵犯可预测胶质瘤患者的异柠檬酸脱氢酶状态

Nonenhancing Margin and Pial Invasion in Magnetic Resonance Imaging can Predict Isocitrate Dehydrogenase Status in Glioma Patients.
PubMed 文献 · World Neurosurg · 2025-01-26

本研究分析113例2级或3级胶质瘤患者(66例IDH突变型,47例IDH野生型),将影像特征、主诉和起病症状整合入逻辑回归模型预测IDH突变和1p/19q共缺失状态,并用癌症基因组图谱公共数据库进行外部验证。结果显示,边缘光滑无强化和软脑膜侵犯是IDH突变的显著预测因素,比值比分别为3.55(P=0.03)和7.89(P=1.0×10-3);仅用Visually Accessible Rembrandt Images特征集预测IDH突变状态的曲线下面积为0.83,加入临床信息和起病症状后分别增至0.85(预测IDH突变)和0.87(预测1p/19q共缺失)。

要点

  • 边缘光滑无强化和软脑膜侵犯是IDH突变的显著预测因素,比值比分别为3.55(P=0.03)和7.89(P=1.0×10-3)。
  • 仅用Visually Accessible Rembrandt Images特征集预测IDH突变的曲线下面积为0.83。
  • 加入临床信息和起病症状后,预测IDH突变和1p/19q共缺失的曲线下面积分别为0.85和0.87。

核心结论

  • IDH突变型胶质瘤更可能表现为边缘光滑无强化和软脑膜侵犯。
  • 作者认为,临床实践中影像预测可使IDH突变评估从术后结果转变为术前指导指标,有助于为低级别胶质瘤患者提供更精准的治疗。

研究设计与样本

  • 研究纳入113例2级或3级胶质瘤患者,其中66例为IDH突变型,47例为IDH野生型。
  • 将影像特征集、主诉和起病症状整合入逻辑回归模型,预测IDH突变和1p/19q共缺失状态。
  • 采用受试者工作特征曲线和曲线下面积分析,并使用癌症基因组图谱公共数据库进行外部验证。

主要发现

  • 边缘光滑无强化预测IDH突变的比值比为3.55(P=0.03)。
  • 软脑膜侵犯预测IDH突变的比值比为7.89(P=1.0×10-3)。
  • 仅用Visually Accessible Rembrandt Images特征集预测IDH突变状态的曲线下面积为0.83。
  • 加入临床信息后预测IDH突变的曲线下面积为0.85,加入起病症状后预测1p/19q共缺失的曲线下面积为0.87。

临床怎么用

  • 作者认为,临床实践中影像预测可使IDH突变评估从术后结果转变为术前指导指标,有助于为低级别胶质瘤患者提供更精准的治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The presence of isocitrate dehydrogenase (IDH) mutations and 1p/19q codeletion significantly influences the diagnosis and prognosis of patients with lower-grade gliomas (LGGs). The ability to predict these molecular signatures preoperatively can inform surgical strategies. This study sought to establish an interpretable imaging feature set for predicting molecular signatures and overall survival in LGGs. METHODS: A cohort of 113 patients with grade 2 or 3 glioma (66 with mutated IDH and 47 with wild-type IDH) was analyzed. The feature set, chief complaints, and onset symptoms were integrated into a logistic regression model to predict IDH mutation and 1p/19q codeletion statuses. Receiver operator characteristic and area under the curve analyses were performed. The predictive model was externally validated using a public database from The Cancer Genome Atlas. RESULTS: Smooth nonenhancing margin and pial invasion were significant predictors of IDH mutation, with odds ratio values of 3.55 (P = 0.03) and 7.89 (P = 1.0 × 10-3), respectively. Using the Visually Accessible Rembrandt Images feature set alone to predict IDH mutation status yielded an area under the curve value of 0.83, which increased to 0.85 and 0.87 when incorporating clinical information and onset symptoms for predicting IDH mutation and 1p/19q codeletion, respectively. CONCLUSIONS: Gliomas with IDH mutations were more likely to exhibit smooth nonenhancing margins and pial invasion. In clinical practice, imaging prediction allows for the assessment of IDH mutation to shift from a postoperative outcome to a preoperative guidance indicator, facilitating more precise treatment for patients with LGGs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yang L, Xie X, Zhang J, et al. Nonenhancing Margin and Pial Invasion in Magnetic Resonance Imaging can Predict Isocitrate Dehydrogenase Status in Glioma Patients. World Neurosurg. 2025. PMID: 39732457. doi:10.1016/j.wneu.2024.123624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。